Extreme Networks (NASDAQ: EXTR) 19.8% LOWER; sees Q3 revenue of $118-$120 million, versus the consensus of $135.3 million. Sees non-GAAP EPS of ($0.09)-($0.07) versus the consensus of breakeven.
Medicines Co. (NASDAQ: MDCO) 7.4% LOWER; announced preliminary worldwide net revenue for the first quarter of 2015. The Company expects worldwide net revenue in the range of $125 million to $130 million for the first quarter of 2015, which reflects a 29% to 26% decrease from the $177.2 million in worldwide net revenue reported for the first quarter of 2014. The decrease in worldwide net revenue is a result of